Multiomics Profiling Reveals Signatures of Dysmetabolism in Urban Populations in Central India.

diabetes mellitus dysmetabolism geography glycome host–microbe interactions multiomics

Journal

Microorganisms
ISSN: 2076-2607
Titre abrégé: Microorganisms
Pays: Switzerland
ID NLM: 101625893

Informations de publication

Date de publication:
12 Jul 2021
Historique:
received: 08 05 2021
revised: 27 06 2021
accepted: 07 07 2021
entrez: 7 8 2021
pubmed: 8 8 2021
medline: 8 8 2021
Statut: epublish

Résumé

Non-communicable diseases (NCDs) have become a major cause of morbidity and mortality in India. Perturbation of host-microbiome interactions may be a key mechanism by which lifestyle-related risk factors such as tobacco use, alcohol consumption, and physical inactivity may influence metabolic health. There is an urgent need to identify relevant dysmetabolic traits for predicting risk of metabolic disorders, such as diabetes, among susceptible Asian Indians where NCDs are a growing epidemic. Here, we report the first in-depth phenotypic study in which we prospectively enrolled 218 adults from urban and rural areas of Central India and used multiomic profiling to identify relationships between microbial taxa and circulating biomarkers of cardiometabolic risk. Assays included fecal microbiota analysis by 16S ribosomal RNA gene amplicon sequencing, quantification of serum short chain fatty acids by gas chromatography-mass spectrometry, and multiplex assaying of serum diabetic proteins, cytokines, chemokines, and multi-isotype antibodies. Sera was also analysed for Multiple hallmarks of dysmetabolism were identified in urbanites and young overweight adults, the majority of whom did not have a known diagnosis of diabetes. Association analyses revealed several host-microbe and metabolic associations. Host-microbe and metabolic interactions are differentially shaped by body weight and geographic status in Central Indians. Further exploration of these links may help create a molecular-level map for estimating risk of developing metabolic disorders and designing early interventions.

Sections du résumé

BACKGROUND BACKGROUND
Non-communicable diseases (NCDs) have become a major cause of morbidity and mortality in India. Perturbation of host-microbiome interactions may be a key mechanism by which lifestyle-related risk factors such as tobacco use, alcohol consumption, and physical inactivity may influence metabolic health. There is an urgent need to identify relevant dysmetabolic traits for predicting risk of metabolic disorders, such as diabetes, among susceptible Asian Indians where NCDs are a growing epidemic.
METHODS METHODS
Here, we report the first in-depth phenotypic study in which we prospectively enrolled 218 adults from urban and rural areas of Central India and used multiomic profiling to identify relationships between microbial taxa and circulating biomarkers of cardiometabolic risk. Assays included fecal microbiota analysis by 16S ribosomal RNA gene amplicon sequencing, quantification of serum short chain fatty acids by gas chromatography-mass spectrometry, and multiplex assaying of serum diabetic proteins, cytokines, chemokines, and multi-isotype antibodies. Sera was also analysed for
RESULTS RESULTS
Multiple hallmarks of dysmetabolism were identified in urbanites and young overweight adults, the majority of whom did not have a known diagnosis of diabetes. Association analyses revealed several host-microbe and metabolic associations.
CONCLUSIONS CONCLUSIONS
Host-microbe and metabolic interactions are differentially shaped by body weight and geographic status in Central Indians. Further exploration of these links may help create a molecular-level map for estimating risk of developing metabolic disorders and designing early interventions.

Identifiants

pubmed: 34361920
pii: microorganisms9071485
doi: 10.3390/microorganisms9071485
pmc: PMC8307859
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : NIHR Nottingham Digestive Diseases Biomedical Research Centre
ID : NA
Organisme : University of Nottingham
ID : Anne McLaren Fellowship
Organisme : Nottingham Trent University
ID : Quality Research Funds
Organisme : NIDDK NIH HHS
ID : K01 DK111794
Pays : United States
Organisme : NIHR Surgical Reconstruction Microbiology Research Centre
ID : NA
Organisme : Crohn's and Colitis Foundation
ID : Litwin initiative
Organisme : European Structural and Investment Funds
ID : KK.01.2.2.03.0006
Organisme : Croatian National Centre of Research Excellence in Personalized Healthcare
ID : KK.01.1.1.01.0010

Références

Nat Commun. 2015 Mar 25;6:6505
pubmed: 25807110
Methods Mol Biol. 2017;1503:13-19
pubmed: 27743355
Biochemistry (Mosc). 2015 Jul;80(7):934-42
pubmed: 26542006
Lancet. 2017 Sep 16;390(10100):1211-1259
pubmed: 28919117
Nat Med. 2019 Dec;25(12):1822-1832
pubmed: 31806905
Front Immunol. 2012 Apr 04;3:66
pubmed: 22566947
Diabetologia. 2001 Sep;44(9):1094-101
pubmed: 11596662
Biochim Biophys Acta. 2016 Aug;1860(8):1574-82
pubmed: 26500099
Nature. 2015 Feb 26;518(7540):S14-5
pubmed: 25715276
Lancet Glob Health. 2018 Dec;6(12):e1352-e1362
pubmed: 30219315
Sci Data. 2019 Dec 19;6(1):328
pubmed: 31857590
Methods. 2018 Oct 1;149:49-58
pubmed: 29704662
Diabetol Metab Syndr. 2014 Apr 03;6(1):50
pubmed: 24694251
Diabetologia. 2017 Dec;60(12):2352-2360
pubmed: 28905229
Front Microbiol. 2017 Jun 30;8:1226
pubmed: 28713353
Nat Methods. 2016 Jul;13(7):581-3
pubmed: 27214047
Cell Immunol. 2018 Nov;333:65-79
pubmed: 30107893
PLoS One. 2020 Oct 19;15(10):e0240971
pubmed: 33075086
Diabetes Metab Syndr Obes. 2014 Dec 04;7:587-91
pubmed: 25506234
FEBS Lett. 2019 Jul;593(13):1598-1615
pubmed: 31215021
Curr Obes Rep. 2019 Sep;8(3):317-332
pubmed: 31175629
FEBS Lett. 2019 Nov;593(21):2966-2976
pubmed: 31509238
Appl Environ Microbiol. 2011 May;77(10):3219-26
pubmed: 21421784
Gut. 2021 Jan;70(1):92-105
pubmed: 33106354
Endocr Pract. 2016 Oct;22(10):1224-1234
pubmed: 27409822
J Clin Immunol. 2014 Jul;34 Suppl 1:S12-21
pubmed: 24691998
Int J Mol Sci. 2019 May 18;20(10):
pubmed: 31109071
Cell Host Microbe. 2016 Aug 10;20(2):202-14
pubmed: 27476413
EBioMedicine. 2020 Jan;51:102590
pubmed: 31901868
Immunogenetics. 1994;39(3):187-93
pubmed: 8276465
Gastroenterology. 2019 Dec;157(6):1676-1678.e3
pubmed: 31476300
J Transl Med. 2019 May 14;17(1):155
pubmed: 31088492
J Glob Health. 2014 Jun;4(1):010404
pubmed: 24976963
Genome Biol. 2011 Jun 24;12(6):R60
pubmed: 21702898
Gut Microbes. 2020 Nov 9;12(1):1752605
pubmed: 32459982
Diabetes Care. 2016 May;39(5):833-46
pubmed: 27208380
Lancet. 2017 Dec 2;390(10111):2437-2460
pubmed: 29150201
J Neurosurg. 2019 Nov 22;:1-8
pubmed: 31756713
Lancet Diabetes Endocrinol. 2017 Aug;5(8):585-596
pubmed: 28601585
Lancet Glob Health. 2018 Dec;6(12):e1262-e1263
pubmed: 30292427
Am J Clin Nutr. 2013 Jul;98(1):111-20
pubmed: 23719549
Front Immunol. 2019 Mar 11;10:277
pubmed: 30915065
Front Endocrinol (Lausanne). 2019 Sep 27;10:649
pubmed: 31611845
Gastroenterology. 2018 Apr;154(5):1320-1333.e10
pubmed: 29309774
J Family Med Prim Care. 2019 Feb;8(2):326-329
pubmed: 30984632
Nature. 2019 May;569(7758):663-671
pubmed: 31142858
Science. 2018 Mar 23;359(6382):1376-1383
pubmed: 29519916
J Clin Endocrinol Metab. 2011 Jun;96(6):1654-63
pubmed: 21602457
J Diabetes Res. 2019 Apr 4;2019:2310235
pubmed: 31089471
Curr Protoc Bioinformatics. 2019 Dec;68(1):e86
pubmed: 31756036
Diabetes Res Clin Pract. 2015 Nov;110(2):172-82
pubmed: 26432412
J Clin Invest. 2011 Jun;121(6):2111-7
pubmed: 21633179
J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Feb 5;784(2):395-403
pubmed: 12505787

Auteurs

Tanya M Monaghan (TM)

NIHR Nottingham Biomedical Research Centre, University of Nottingham, Nottingham NG7 2UH, UK.
Nottingham Digestive Diseases Centre, School of Medicine, University of Nottingham, Nottingham NG7 2UH, UK.

Rima N Biswas (RN)

Biochemistry Research Laboratory, Dr. G.M. Taori Central India Institute of Medical Sciences, Nagpur 440010, India.

Rupam R Nashine (RR)

Biochemistry Research Laboratory, Dr. G.M. Taori Central India Institute of Medical Sciences, Nagpur 440010, India.

Samidha S Joshi (SS)

Biochemistry Research Laboratory, Dr. G.M. Taori Central India Institute of Medical Sciences, Nagpur 440010, India.

Benjamin H Mullish (BH)

Division of Digestive Diseases, Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, London SW7 2AZ, UK.

Anna M Seekatz (AM)

Department of Biological Sciences, Clemson University, Clemson, SC 29631, USA.

Jesus Miguens Blanco (JM)

Division of Digestive Diseases, Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, London SW7 2AZ, UK.

Julie A K McDonald (JAK)

Division of Digestive Diseases, Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, London SW7 2AZ, UK.
MRC Centre for Molecular Bacteriology and Infection, Imperial College London, London SW7 2AZ, UK.

Julian R Marchesi (JR)

Division of Digestive Diseases, Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, London SW7 2AZ, UK.

Tung On Yau (TO)

Department of Biosciences, John van Geest Cancer Research Centre, Centre for Health Aging and Understanding Disease, School of Science and Technology, Nottingham Trent University, Nottingham NG7 2UH, UK.

Niki Christodoulou (N)

Department of Biosciences, John van Geest Cancer Research Centre, Centre for Health Aging and Understanding Disease, School of Science and Technology, Nottingham Trent University, Nottingham NG7 2UH, UK.

Maria Hatziapostolou (M)

Department of Biosciences, John van Geest Cancer Research Centre, Centre for Health Aging and Understanding Disease, School of Science and Technology, Nottingham Trent University, Nottingham NG7 2UH, UK.

Maja Pucic-Bakovic (M)

Glycoscience Research Laboratory, Genos Ltd., Borongajska cesta 83H, 10000 Zagreb, Croatia.

Frano Vuckovic (F)

Glycoscience Research Laboratory, Genos Ltd., Borongajska cesta 83H, 10000 Zagreb, Croatia.

Filip Klicek (F)

Glycoscience Research Laboratory, Genos Ltd., Borongajska cesta 83H, 10000 Zagreb, Croatia.

Gordan Lauc (G)

Glycoscience Research Laboratory, Genos Ltd., Borongajska cesta 83H, 10000 Zagreb, Croatia.
Faculty of Pharmacy and Biochemistry, University of Zagreb, 10000 Zagreb, Croatia.

Ning Xue (N)

School of Veterinary Medicine and Science, University of Nottingham, Nottingham NG7 2UH, UK.

Tania Dottorini (T)

School of Veterinary Medicine and Science, University of Nottingham, Nottingham NG7 2UH, UK.

Shrikant Ambalkar (S)

Department of Microbiology and Infection, King's Mill Hospital, Sherwood Forest Hospitals NHS Trust, Sutton in Ashfield NG17 4JL, UK.

Ashish Satav (A)

Mahatma Gandhi Tribal Hospital, MAHAN Trust Melghat, Amravati 605006, India.

Christos Polytarchou (C)

Department of Biosciences, John van Geest Cancer Research Centre, Centre for Health Aging and Understanding Disease, School of Science and Technology, Nottingham Trent University, Nottingham NG7 2UH, UK.

Animesh Acharjee (A)

Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham B15 2TT, UK.
Institute of Translational Medicine, University Hospitals Birmingham, Foundation Trust, Birmingham B15 2TT, UK.
NIHR Surgical Reconstruction and Microbiology Research Centre, University Hospital Birmingham, Birmingham B15 2WB, UK.

Rajpal Singh Kashyap (RS)

Biochemistry Research Laboratory, Dr. G.M. Taori Central India Institute of Medical Sciences, Nagpur 440010, India.

Classifications MeSH